COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 2152: Articles 21511-21520  | Next

SARS-CoV-2 RBD mutations, ACE2 genetic polymorphism, and stability of the virus-receptor complex: The COVID-19 host-pathogen nexus.
Ashoor, D., Ben Khalaf, N., Marzouq, M., Jarjanazi, H., Fathallah, M. D.
10.1101/2020.10.23.352344 — Posted: 2020-10-24
Ivermectin repurposing for COVID-19 therapy: Safety and pharmacokinetic assessment of a novel nasal spray formulation in a pig model
Errecalde, J., Lifschitz, A., Vecchioli, G., Ceballos, L., Errecalde, F., Ballent, M., Marin, G., Daniele, M., Turic, E., Spitzer, E., Toneguzzo, F., Gold, S., Krolewiecki, A., Alvarez, L., Lanusse, C.
10.1101/2020.10.23.352831 — Posted: 2020-10-24
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
Mellott, D., Tseng, C.-T., Drelich, A., Fajtova, P., Chenna, B. C., Kostomiris, D., Hsu, J. C., Zhu, J., Taylor, Z., Tat, V., Katzfuss, A., Li, L., Giardini, M. A., Skinner, D., Hirata, K., Beck, S., Carlin, A. F., Clark, A. E., Berreta, L., Maneval, D., Frueh, F., Hurst, B. L., Wang, H., Kocurek, K. I., Raushel, F. M., O'Donoghue, A., Siqueira-Neto, J. L., Meek, T. D., McKerrow, J. H.
10.1101/2020.10.23.347534 — Posted: 2020-10-24
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut
Triana, S., Metz Zumaran, C., Ramirez, C., Kee, C., Doldan, P., Shahraz, M., Schraivogel, D., Gschwind, A. R., Steinmetz, L. M., Herrmann, C., Alexandrov, T., Boulant, S., Stanifer, M. L.
10.1101/2020.10.21.348854 — Posted: 2020-10-24
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
Le, B. L., Andreoletti, G., Oskotsky, T., Vallejo-Gracia, A., Rosales, R., Yu, K. Z., Kosti, I., Leon, K. E., Bunis, D. G., Li, C., Kumar, G. R., White, K. M., Garcia-Sastre, A. E., Ott, M., Sirota, M.
10.1101/2020.10.23.352666 — Posted: 2020-10-23
Simulation and prediction of further spread of COVID-19 in The Republic of Serbia by SEIRDS model of disease transmission
Stanojevic, S. G., Ponjavic, M., Stanojevic, S., Stevanovic, A., Radojicic, S.
10.1101/2020.10.21.20216986 — Posted: 2020-10-23
The effect of COVID-19 on critical care research: A prospective longitudinal multinational survey
Duffett, M., Cook, D. J., Strong, G., Lee, J. H., Kho, M. E.
10.1101/2020.10.21.20216945 — Posted: 2020-10-23
Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in Argentina
Ojeda, D., Gonzalez Lopez Ledesma, M. M., Palleres, H., Costa Navarro, G., Sanchez, L., Perazzi, B., Villordo, S., Alvarez, D., BioBanco Working Group, , Echavarria, M., Oguntuyo, K. Y., Stevens, C., Lee, B., Carradori, J., Caramelo, J., Yanovsky, M., Gamarnik, A.
10.1101/2020.10.21.20216960 — Posted: 2020-10-23
Exposome changes in primary school children following the wide population non-pharmacological interventions implemented due to COVID-19 in Cyprus: a national survey
Konstantinou, C., Andrianou, X. D., Constantinou, A., Perikkou, A., Markidou, E., Christophi, C. A., Makris, K. C.
10.1101/2020.10.21.20216978 — Posted: 2020-10-23
Twitter Engagement of U.S. Psychiatry Residency Programs with Black Lives Matter and Coronavirus Disease 2019 (COVID-19)
El-Gabalawy, O., Kim, C., Chen, A., Kamal, S.
10.1101/2020.10.20.20215723 — Posted: 2020-10-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).